Carbohydrate Polymer Technologies and Applications, published by ELSEVIER, is an esteemed open access journal that has been fostering innovation in the field of carbohydrate polymer research since its inception in 2020. With its ISSN 2666-8939, this journal is dedicated to exploring the intersections of analytical chemistry, biochemistry, biotechnology, and materials science, making significant contributions to our understanding of carbohydrate polymers and their diverse applications across various industries. Notably, it has attained a prominent position in various categories, reflecting its quality and impact: ranked Q1 in Analytical Chemistry, Biotechnology, and several Materials Science disciplines, while maintaining strong positions in the Q2 and other quartiles. Additionally, with impressive Scopus rankings—14th in Chemistry (miscellaneous) and 23rd in Analytical Chemistry—it stands at the forefront of scholarly dialogue in these areas, appealing to researchers, professionals, and students alike. The journal's commitment to open access facilitates wider dissemination of knowledge and enhances collaborative research, solidifying its role as a pivotal resource for advancing carbohydrate polymer technologies.

The Journal of Experimental Nanoscience, published by Taylor & Francis Ltd, is an esteemed open-access journal dedicated to advancing the field of nanoscience and its applications across various disciplines. Since its establishment, the journal has aimed to provide a comprehensive platform for researchers and professionals to disseminate innovative findings in nanotechnology, bioengineering, and materials science. With an ISSN of 1745-8080 and E-ISSN of 1745-8099, this journal has been pivotal in promoting high-quality research in its converged years from 2006 to 2024. Recognized for its contributions, it currently holds a Q3 ranking in core categories such as Bioengineering, Biomedical Engineering, Materials Science, and Nanoscience and Nanotechnology. Although its H-index is not specified, its Scopus ranks reflect its growing influence, with notable percentiles in various engineering fields. By offering open access since 2016, the Journal of Experimental Nanoscience enhances the accessibility of vital research to a global audience. Researchers, professionals, and students will find this journal an invaluable resource for staying abreast of the latest advancements and breakthroughs in nanoscience.

ChemNanoMat is a prestigious academic journal published by WILEY-V C H VERLAG GMBH, dedicated to the rapidly evolving fields of nanoscale materials and their applications in diverse areas such as biomaterials, energy engineering, and environmental sustainability. With the journal's ISSN 2199-692X and recognized quality, as evidenced by its Q2 rankings across multiple categories—including Biomaterials and Renewable Energy—ChemNanoMat serves as a crucial platform for researchers, professionals, and students to disseminate their findings and foster collaborations. Operating from Germany, the journal encourages the exploration of innovative materials solutions to meet tomorrow's challenges. While it does not currently offer open access options, it remains highly regarded in the academic community with a competitive impact factor that emphasizes its relevance and influence in guiding future research directions. Covering a broad scope from 2015 through 2024, ChemNanoMat is key for anyone invested in the advancement of materials chemistry and related scientific fields.

Cancer Nanotechnology is a cutting-edge peer-reviewed journal dedicated to advancing the field of cancer research through innovative nanotechnology applications. Published by SPRINGER WIEN, this open-access journal, established in 2010, provides a vital platform for the dissemination of high-quality research with a focus on the intersection of nanotechnology, oncology, and biomedical engineering. With a commitment to promoting accessibility and fostering collaboration, Cancer Nanotechnology has gained impressive rankings within specialized categories, including Q2 in Biomedical Engineering and Pharmaceutical Science. The journal's rigorous selection process ensures that only the most impactful studies reach its audience, making it a must-read for researchers, professionals, and students eager to explore the latest advancements and methodologies in cancer treatment. With its scope encompassing critical topics that bridge multiple disciplines—including physical chemistry and toxicology—Cancer Nanotechnology positions itself as an influential resource for shaping the future of cancer therapies.

Nano Today is a prestigious journal published by ELSEVIER SCI LTD that stands at the forefront of nanoscience and nanotechnology research. With an impact factor that underscores its significance, this journal has achieved remarkable rankings in several key categories as of 2023, including Q1 positions in Bioengineering, Biomedical Engineering, Biotechnology, Materials Science, and Pharmaceutical Science, making it an essential resource for scholars and professionals alike. ISSN 1748-0132 and E-ISSN 1878-044X, the journal serves as a vital platform for disseminating cutting-edge research findings and innovative applications in the field. Although open access options are not available, the journal's rich repository of peer-reviewed articles provides invaluable insights into the latest advancements in nanotechnologies. Based in the Netherlands, Nano Today not only connects a global network of researchers but also propels forward the conversation on the transformative potential of nanomaterials across multiple disciplines. With a commitment to advancing knowledge and fostering innovation, Nano Today is an indispensable tool for academics and practitioners dedicated to pushing the boundaries of scientific exploration.

Micro & Nano Letters is a prominent open-access journal published by WILEY, dedicated to advancing the fields of micro and nanoscale science and technology. Since its inception in 2007, the journal has been a valuable resource for researchers, professionals, and students, delivering high-quality research that supports innovation and collaboration in bioengineering, biomedical engineering, condensed matter physics, materials science, and nanoscience. With an impact factor that reflects its growing influence, Micro & Nano Letters has earned recognition in various Scopus categories, including a Q3 ranking in both Condensed Matter Physics and Materials Science as of 2023. Its commitment to open access, established in 2021, ensures that the latest developments in micro- and nanotechnologies are accessible to a global audience, fostering a multidisciplinary dialogue across academia and industry. The journal continues to play a critical role in disseminating cutting-edge research and promoting technological advancements worldwide.

Nanotoxicology is a pioneering journal published by Taylor & Francis Ltd, dedicated to the critical examination of the toxicity of nanomaterials and their implications in biomedical engineering, nanoscience, and toxicology. With an ISSN of 1743-5390 and E-ISSN of 1743-5404, this journal has established itself as a significant player in its field since its inception in 2007. Classified within the Q2 category for 2023 in major categories such as Biomedical Engineering, Nanoscience and Nanotechnology, and Toxicology, it reflects its robust impact across interdisciplinary research. Notably, its Scopus rankings position it in the top percentile, underscoring its influence in pharmacology and toxicology. The journal offers scholars, researchers, and professionals a platform for sharing pioneering studies and reviews, thereby advancing the understanding of nanomaterial interactions with biological systems. Published from the United Kingdom, Nanotoxicology recognizes the growing importance of nanotechnology in health and environmental contexts, making it an essential resource for anyone engaged in this rapidly evolving field.

Nanomedicine Journal, published by Mashhad University of Medical Sciences, serves as a vital platform for research and developments in the dynamic field of nanotechnology applied to medicine. With an ISSN of 2322-3049 and an E-ISSN of 2322-5904, this Open Access journal, operational since 2013, makes cutting-edge research freely accessible to encourage collaborative efforts in this rapidly evolving domain. The journal navigates various areas, including bioengineering, biomedical engineering, materials science, and pharmacology, holding prestigious rankings in categories relevant to these fields. The 2023 Scopus Rankings reveal its significant standing within the scientific community, particularly with a 76th percentile in general medicine. By bridging the gap between laboratory technologies and clinical applications, the Nanomedicine Journal aims to empower researchers, professionals, and students alike to contribute to the innovative landscape of nanomedicine. With a convergence period extending from 2019 to 2024 and an established reputation, this journal is essential for those pursuing advancements in therapeutic solutions and diagnostics through nanotechnology.

Artificial Cells Nanomedicine and Biotechnology is a prestigious peer-reviewed journal published by TAYLOR & FRANCIS LTD, specializing in the rapidly evolving fields of biomedical engineering, biotechnology, and nanomedicine. Established in 2013 and operating under an open-access model since 2019, the journal aims to bridge the gap between fundamental science and real-world medical applications, showcasing cutting-edge research that advances our understanding of artificial cells and their biotechnological applications. With an impressive impact factor and ranking in the Q2 quartile across various categories, including Biomedical Engineering, Medicine, and Pharmaceutical Sciences, the journal is a leading platform for innovative studies that contribute significantly to the realm of healthcare and therapeutic development. Researchers, professionals, and students alike will find invaluable insights and advancements within its pages, positioning it as a vital resource for those dedicated to pushing the boundaries of science and improving patient outcomes.

Nanomedicine, published by Future Medicine Ltd, is a premier academic journal dedicated to the rapidly evolving field of nanotechnology in medicine. With an emphasis on innovative research and applications, this journal encompasses a broad spectrum of topics including bioengineering, biomedical engineering, and nanoscience, among others. Featuring an impressive Q1 ranking in Development and multiple Q2 rankings across significant categories, it serves as a pivotal resource for researchers and professionals aiming to stay at the forefront of advancements in these disciplines. While the journal is not open access, it is accessible through various institutional subscriptions, ensuring wide dissemination of cutting-edge findings. Notably, it has achieved substantial impact within the scientific community, indicated by its high rankings in Scopus and overall commitment to enhancing the understanding and application of nanomedicine. This journal is a vital conduit for fostering collaborations and innovations that transcend traditional medical paradigms.